115 related articles for article (PubMed ID: 480951)
1. Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED).
Buzdar AU; Blumenschein GR; Smith TL; Tashima CK; Hortobagyi GN; Yap HY; Gutterman JU; Hersh EM; Gehan EA
J Surg Oncol; 1979; 12(1):27-40. PubMed ID: 480951
[TBL] [Abstract][Full Text] [Related]
2. Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy.
Hortobagyi GN; Spanos W; Montague ED; Buzdar AU; Yap HY; Blumenschein GR
Int J Radiat Oncol Biol Phys; 1983 May; 9(5):643-50. PubMed ID: 6343312
[TBL] [Abstract][Full Text] [Related]
3. Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma.
Krutchik AN; Buzdar AU; Blumenschein GR; Hortobagyi GN; Tashima CK; Gutterman JU; Yap HY; Hersh EM
J Surg Oncol; 1979; 11(4):325-32. PubMed ID: 109703
[TBL] [Abstract][Full Text] [Related]
4. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
Cancer; 1979 Apr; 43(4):1225-33. PubMed ID: 445325
[TBL] [Abstract][Full Text] [Related]
5. Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer.
Buzdar AU; Gutterman JU; Blumenschein GR; Hortobagyi GN; Tashima CK; Smith TL; Hersh EM; Freireich EJ; Gehan EA
Cancer; 1978 Mar; 41(3):1064-75. PubMed ID: 638948
[TBL] [Abstract][Full Text] [Related]
6. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
Cancer; 1979 Nov; 44(5):1955-62. PubMed ID: 387212
[TBL] [Abstract][Full Text] [Related]
7. Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin.
Hortobagyi GN; Yap HY; Blumenschein GR; Gutterman JU; Buzdar AU; Tashima CK; Hersh EM
Cancer Treat Rep; 1978 Nov; 62(11):1685-92. PubMed ID: 728894
[TBL] [Abstract][Full Text] [Related]
8. Combined chemoimmunotherapy for advanced breast cancer: a comparison of BCG and levamisole.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Yap HY; Buzdar AU; Tashima CK; Burgess MA; Hersh EM
Cancer; 1979 Mar; 43(3):1112-22. PubMed ID: 427716
[TBL] [Abstract][Full Text] [Related]
9. Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancer.
Hortobagyi GN; Blumenschein GR; Tashima CK; Buzdar AU; Burgess MA; Livingston RB; Valdivieso M; Gutterman JU; Hersh EM; Bodey GP
Cancer; 1979 Aug; 44(2):398-405. PubMed ID: 383255
[TBL] [Abstract][Full Text] [Related]
10. Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.
Gutterman JU; Cardenas JO; Blumenschein GR; Hortobagyi G; Burgess MA; Livingston RB; Mavligit GM; Freireich EJ; Gottlieb JA; Hersh EM
Br Med J; 1976 Nov; 2(6046):1222-5. PubMed ID: 791447
[TBL] [Abstract][Full Text] [Related]
11. Combination chemoimmunotherapy with FAC-BCG for metastatic breast cancer: the impact of CMF maintenance chemotherapy.
Hortobagyi GN; Blumenschein GR; Buzdar AU; Yap HY; Schell FC; Barnes BC; Burgess MA
J Surg Oncol; 1981; 18(2):163-72. PubMed ID: 7300363
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trial.
Buzdar AU; Blumenschein GR; Smith TL; Powell KC; Hortobagyi GN; Yap HY; Schell FC; Barnes BC; Ames FC; Martin RG
Cancer; 1984 Feb; 53(3):384-9. PubMed ID: 6362814
[TBL] [Abstract][Full Text] [Related]
13. Multimodal treatment of locoregionally advanced breast cancer.
Hortobagyi GN; Blumenschein GR; Spanos W; Montague ED; Buzdar AU; Yap HY; Schell F
Cancer; 1983 Mar; 51(5):763-8. PubMed ID: 6687377
[TBL] [Abstract][Full Text] [Related]
14. Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer.
Buzdar AU; Smith TL; Powell KC; Blumenschein GR; Gehan EA
Breast Cancer Res Treat; 1982; 2(2):163-9. PubMed ID: 6897369
[TBL] [Abstract][Full Text] [Related]
15. Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up report.
Buzdar AU; Blumenschein GR; Gutterman JU; Tashima CK; Hortobagyi GN; Smith TL; Campos LT; Wheeler WL; Hersh EM; Freireich EJ; Gehan EA
JAMA; 1979 Oct; 242(14):1509-13. PubMed ID: 470088
[TBL] [Abstract][Full Text] [Related]
16. FAC + BCG as adjuvant therapy in breast cancer: an 8-year update.
Blumenschein GR; Buzdar AU; Hortobagyi GN
Recent Results Cancer Res; 1984; 96():129-32. PubMed ID: 6528087
[No Abstract] [Full Text] [Related]
17. Management of inflammatory carcinoma of breast with combined modality approach - an update.
Buzdar AU; Montague ED; Barker JL; Hortobagyi GN; Blumenschein GR
Cancer; 1981 Jun; 47(11):2537-42. PubMed ID: 6790155
[TBL] [Abstract][Full Text] [Related]
18. Results of adjuvant chemotherapy trials in breast cancer at M. D. Anderson Hospital and Tumor Institute.
Buzdar AU; Hortobagyi GN; Marcus CE; Smith TL; Martin R; Gehan EA
NCI Monogr; 1986; (1):81-5. PubMed ID: 3534594
[TBL] [Abstract][Full Text] [Related]
19. Follow-up adjuvant chemotherapy and chemoimmunotherapy for stage II and III carcinoma of the breast.
Cohen E; Scanlon EF; Caprini JA; Cunningham MP; Oviedo MA; Robinson B; Knox KL
Cancer; 1982 May; 49(9):1754-61. PubMed ID: 7042073
[TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCG.
Britell JC; Ahmann DL; Bisel HF; Frytak S; Ingle JN; Rubin J; O'Fallon JR
Cancer Clin Trials; 1979; 2(4):345-50. PubMed ID: 394870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
